<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">The median cumulative number of CD34
 <sup>+</sup> cells/kg collected was comparable between the two treatment groups (5.35 × 10
 <sup>6</sup> and 5.24 × 10
 <sup>6</sup> for the FD and WB groups, respectively). The fold increase from baseline in peripheral blood CD34+ cells on Day 5 was similar in the FD and WB dosing groups (mean fold increases of 5.43 and 5.09, respectively) (Supplementary Table S
 <xref rid="MOESM2" ref-type="media">1</xref>) despite higher plerixafor exposure in the FD cohort.
</p>
